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Summary
The intracellular parasite Toxoplasma gondii converts
from a rapidly replicating tachyzoite form during acute
infection to a quiescent encysted bradyzoite stage that
persists inside long-lived cells during chronic infec-
tion. Bradyzoites adopt reduced metabolism and slow
replication while waiting for an opportunity to recru-
desce the infection within the host. Interconversion
between these two developmental stages is character-
ized by expression of glycolytic isoenzymes that play
key roles in parasite metabolism. The parasite genome
encodes two isoforms of lactate dehydrogenase
(LDH1 and LDH2) and enolase (ENO1 and ENO2) that
are expressed in a stage-specific manner. Expression
of different isoforms of these enzymes allows T. gondii
to rapidly adapt to diverse metabolic requirements
necessary for either a rapid replication of the tachy-
zoite stage or a quiescent lifestyle typical of the brady-
zoites. Herein we identified unspliced forms of LDH
and ENO transcripts produced during transition
between these two parasite stages suggestive of an
intron retention mechanism to promptly exchange gly-
colytic isoforms for rapid adaptation to environmental
changes. We also identified key regulatory elements in
the ENO transcription units, revealing cooperation
between the ENO2 5′-untranslated region and the
ENO2 intron, along with identifying a role for the ENO1
3′-untranslated region in stage-specific expression.
Introduction
Toxoplasma gondii is a highly successful parasite capable
of infecting all warm-blooded vertebrates including ∼ 30%
of the total human population. Its success relies on effec-
tive routes of transmission and an ability to avoid causing
severe disease by differentiating from a rapidly replicating
tachyzoite form to a slow dividing bradyzoite form.
Whereas tachyzoites elicit a vigorous immune response,
semi-dormant bradyzoites persist virtually unscathed in
the host, residing indefinitely inside cysts harbored within
several types of host cells including myocytes and
neurons (Dubey et al., 1998; Weiss and Kim, 2000).
Tachyzoites and bradyzoites are further distinguished by
having disparate energy requirements that reflect large
differences of their metabolism. Tachyzoites utilize glyco-
lysis as a major source of energy, generating lactate as
the main product. The tricarboxylic acid (TCA) cycle
metabolism also contributes substantially to energy pro-
duction in this parasite stage. On the other hand, brady-
zoites seem to lack a functional TCA cycle and respiratory
chain (Denton et al., 1996) and rely on catabolism of
starch in amylopectin granules for energy production. So,
glycolysis is necessary for energy production in both
tachyzoites and bradyzoites, although it seems to be the
predominant pathway in bradyzoites (Bohne et al., 1999).
The parasite adapts to these metabolic differences by
expressing different sets of glycolytic enzymes. Two key
enzymes of glycolysis, lactate dehydrogenase (LDH) and
enolase (ENO), are differentially expressed in tachyzoites
and bradyzoites (Tomavo, 2001; Weiss and Kim, 2013).
LDH is a glycolytic enzyme that converts pyruvate to
lactate and plays an indispensable role when glycolysis
becomes the only pathway to provide energy under
anaerobic conditions (Kavanagh et al., 2004). Two copies
of this enzyme are present in Toxoplasma genome, LDH1
and LDH2, which are exclusively expressed in tachyzoites
and bradyzoites respectively (Yang and Parmley, 1995;
1997). LDH2 activity is about three times higher than
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LDH1, probably because of bradyzoite dependence on
amylopectin catabolism (Denton et al., 1996). Moreover,
the LDH2 bradyzoite-specific isoenzyme is resistant to
acidic pH, allowing bradyzoites to tolerate acidification
resulting from amylopectin catabolism to lactate. Stage-
specific knockdown of LDH1 or LDH2 impaired parasite
replication and resulted in a significant reduction of brain
cyst burden in a murine model (Al-Anouti et al., 2004),
indicating important contributions of these isoenzymes to
infection.
The other key glycolytic enzyme, ENO, is also
expressed in two stage-specific isoforms, termed ENO1
and ENO2 in bradyzoites and tachyzoites respectively
(Manger et al., 1998; Yahiaoui et al., 1999; Dzierszinski
et al., 2001; Kibe et al., 2005). ENO converts 2-
phosphoglycerate to phosphoenolpyruvate, and the
tachyzoite-specific isoform ENO2 displays a threefold
greater catalytic rate than the bradyzoite isoform ENO1.
The higher activity of ENO2 might reflect the higher energy
requirement of tachyzoites due to their rapid growth rate.
However, ENO1 is more thermo-stable than the tachyzoite
isoform, a feature that may confer higher resistance to
increased stress (Tomavo, 2001). Moreover, Ferguson
et al. reported that a subpopulation of both ENO isoforms
resides in the parasite nucleus during early intracellular
proliferation and development (Ferguson et al., 2002).
ENO1 nuclear localization seems to be dependent on
ENO2 expression because silencing of this latter alters
nuclear targeting of ENO1 (Holmes et al., 2010). Very
recently, a new study showed that these ENOs are asso-
ciated with nuclear chromatin and regulate gene expres-
sion of numerous gene targets (Mouveaux et al., 2014).
This study also showed that genetic ablation of ENO1
reduced the number of brain cysts in chronically infected
mice and altered expression of several genes in brady-
zoites. These new data suggest that ENO genes play key
roles during tachyzoite-bradyzoite interconversion by
regulating genes involved in differentiation.
Several reports show that expression of key cellular
factors may also be regulated by posttranscription mecha-
nisms such as time-regulated splicing (Averbeck et al.,
2005; Xu et al., 2008; Yap et al., 2012; Boothby et al.,
2013; Zhan, 2013). Among these processes, intron reten-
tion (IR) is a type of alternative splicing exploited by cells
to provide messengers that cannot be translated until a
stimulus triggers splicing of the regulated intron(s), licens-
ing these messengers to produce their coded product
(Boothby et al., 2013).
Herein we provide experimental evidence that expres-
sion of LDH and ENO isoforms is subjected to posttran-
scriptional control. Our findings show for the first time that
parasites regulate splicing to produce unspliced LDH and
ENO transcripts as a prelude to interconversion. Our
results indicate that Toxoplasma exploits an intron-
retention mechanism to prevent synthesis of the glycolytic
enzymes from transcripts generated during the early
phase of the differentiation process. Furthermore, we dis-
sected ENO transcription units to identify the elements
involved in the posttranscriptional regulation of ENO
genes.
Results
IR precludes expression of glycolytic enzyme isoforms
at an inappropriate stage
Tachyzoite-specific LHD1 and ENO2 and bradyzoite-
specific LDH2 and ENO1 each contain a single intron near
the 5′ end of their respective coding sequences (Fig. 1A).
Using ENO1 as bradyzoite marker in reverse transcription-
polymerase chain reaction (RT-PCR) experiments, we
identified in cDNA prepared from in vitro (iTz) and in vivo
(pTz) tachyzoites of PLK strain T. gondii a 1.2 kb PCR
product consistent with an unspliced form of ENO1
(Fig. 1B, lanes 4 and 6 respectively). Sequencing this PCR
product confirmed that it was effectively the unspliced form
of ENO1 containing in-frame stop codons within the intron.
PCR of the corresponding nonreversed transcribed RNAs
showed no amplification, ruling out that the product origi-
nated from genomic DNA contamination. cDNA generated
from T. gondii PLK bradyzoite cysts (Bz) isolated from
infected mouse brains exclusively showed the spliced form
of ENO1 (Fig. 1B, lane 2), indicating that unspliced tran-
scripts were specific to the tachyzoite stage or potentially
the transitional phase during tachyzoite-bradyzoite inter-
conversion. Weak expression of the mature form of ENO1
was also seen in PLK tachyzoites (Fig. 1B, lanes 4 and 6),
perhaps due to the presence of a few spontaneously
converted bradyzoites occurring during normal growth of
this cystogenic strain in vitro and in vivo. The unspliced
form of ENO1 was the only PCR product detectable in
cDNA generated from tachyzoite mRNAs of the poorly
cystogenic strain RH (Fig. 1C, lane 2). Spontaneous con-
version of this type I RH strain in in vitro cultures is very low
or even absent, suggesting that IR occurred in the tachy-
zoite stage. Similar to ENO1, the bradyzoite-specific LDH2
transcript showed IR in tachyzoites (Fig. 1D), as confirmed
by sequencing the PCR product. Together, these results
indicate that unspliced transcripts of bradyzoite-specific
ENO1 and LDH2 are present in tachyzoites, suggesting an
IR mechanism that precludes expression of these proteins
at an inappropriate stage.
To investigate the extent that IR also occurs in brady-
zoites, we converted tachyzoites to in vitro bradyzoites
(iBz) for 10 days in alkaline culture medium and prepared
cDNA from the resulting differentiated parasites. Because
in vitro conversion is not 100% efficient, the cultures are
enriched for bradyzoites, but also contain tachyzoites and
parasites in transition between the two stages. Detection
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of the tachyzoite-specific SAG1 transcript confirmed that
the differentiated cultures contain a mixture of stages
(Fig. 2A, upper panel lane 2). Further analysis of iBz
samples showed that unspliced transcripts of tachyzoite-
specific LDH1 and ENO2 are present in bradyzoites, the
stage in which they are not expressed (Fig. 2A upper
panel lane 3 and Fig. 2B upper panel lane 1 respectively).
In contrast, unspliced transcripts of LDH1 and ENO2 were
absent from in vitro tachyzoites, the stage in which they
are expressed (Fig. 2A bottom panel lane 3 and Fig. 2B
upper panel lane 3 respectively). Collectively, our findings
suggest that IR occurs in both tachyzoites and brady-
zoites to impede expression of ENO and LDH isoforms at
an unsuited stage.
Appropriate expression of ENO2 in tachyzoites depends
on the ENO2 intron
To identify elements of the ENO2 gene that regulate syn-
thesis of this glycolytic enzyme, we designed a series of
Fig. 1. IR in ENO1 and LDH2 transcripts
during the tachyzoite stage.
A. Schematic representation of the genes and
primers used in the study. Exons are
represented as rectangles whereas introns
are indicated with lines linking the exons.
Primers are indicated by arrows.
B. Agarose gel electrophoresis of RT-PCR
products from RNA isolated from PLK cysts
(Bz), in vitro tachyzoites (iTz) or
intraperitoneal tachyzoites (pTz) using primers
E1F/E1R (top panel), E2F/E2R (middle panel)
or T5F/T5R (bottom panel). Schematic
representations of the expected amplification
products of unspliced and spliced transcripts
are indicated to the right of each gel. Positive
(‘+’) and negative (‘–’) signs indicate RNAs
with or without reverse transcriptase
respectively.
C. Only the unspliced form of ENO1 is
detected in cDNA generated from RH
tachyzoite RNA. Agarose gel electrophoresis
of RT-PCR products from RNA using E1F and
E1R primers.
D. LDH2 transcripts show IR in in vitro PLK
tachyzoites (iTz) but not in in vitro bradyzoites
(iBz). RT-PCR was performed using primers
L2F/L2R to detect LDH2 transcripts.
Fig. 2. LDH1 and ENO2 transcripts show IR
in in vitro differentiated bradyzoites.
A. Analysis of LDH1 expression and splicing.
Total RNAs were isolated from either in vitro
PLK tachyzoites (iTz) or PLK parasites grown
in HFF cells with alkaline media (pH 8.2) for 6
days (iBz) and analyzed by RT-PCR using
primers to detect BAG1 (bradyzoite marker,
B1F and B1R primers), SAG1 (tachyzoite
marker, S1F and S1R primers) and LDH1
(L1F and L1R primers) transcripts. Minus
reverse transcriptase control for each set of
primers was performed but not shown in the
figure.
B. Analysis of ENO2 expression and splicing.
RNA isolation and RT-PCR was performed as
in A with E2F and E2R or T5F and T5R
primers.
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red fluorescent protein (RFP) reporter constructs to
dissect the main constituents of the ENO2 expression unit
in stably transfected PLK strain. The basal construct,
named prENO2/RFP, carries a fragment spanning 1930
bp upstream of the ENO2 start codon to drive expression
of RFP (lacking introns) followed by a 683 bp fragment
downstream of the ENO2 stop codon. This construct was
designed based on the largest construct described by
Kibe et al. (2005). Transfection of PLK tachyzoites using
100 μg of the prENO2/RFP vector resulted in low expres-
sion of RFP after 24 h, with few tachyzoites displaying a
barely detectable fluorescence by microscopy (data not
shown). After 8 days of pyrimethamine selection, stable
parasite populations carrying prENO2/RFP vector were
analyzed by flow cytometry. This analysis showed that
RFP was poorly expressed and in a low percentage of
prENO2/RFP transfected parasites (Fig. 3B) that was only
marginally higher than WT (untransfected) parasites
(Fig. 3A). This result was in accordance with that reported
in Kibe et al.’s manuscript where the authors stated that,
based on CAT expression, both ENO genes exhibited
weak promoter activity (Kibe et al., 2005). So, taking in
consideration results on IR obtained above, we wondered
whether the ENO2 intron might have an influence on
ENO2 expression. To assess this, we generated a new
construct, named prENO2/RFP + INTENO2, in which the
ENO2 intron was placed 40 bp downstream of the ATG of
RFP coding region, mirroring the exogenous gene. An
analysis of RFP fluorescence either 24 h posttransfection
or 8 days postpyrimethamine selection showed that RFP
expression was restored by the presence of the ENO2
intron with tachyzoites displaying strong fluorescence
intensity (Fig. 3C). Thus, these findings suggest the
ENO2 intron as a key element for efficient expression
from the ENO2 transcription unit.
The ENO2 5′UTR suppresses RFP expression in
absence of the ENO2 intron
To understand the basis of the ENO2 intron requirement for
RFP expression, we first investigated whether the intron
contained a transcription enhancer. We assessed if the
Fig. 3. The ENO2 transcription unit requires an intron to express RFP. PLK tachyzoites were analyzed as WT parasites (A) or were stably
transfected with either prENO2/RFP (B) or prENO2/RFP + INTENO2 (C) along with a DHFR resistance cassette. After 8 days of pyrimethamine
selection, stably transfected populations were analyzed by flow cytometry. There were 100 000 events counted for each strain. Data are from
one representative experiment out of three with similar results. MFI, mean fluorescence intensity.
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ENO2 intron was capable of conferring expression in a
construct containing the SAG1 promoter lacking its tran-
scriptional activation region by replacing the ENO2 pro-
moter and 5′UTR of prENO2/RFP + INTENO2 with a
sequence beginning 70 bp upstream of the SAG1 tran-
scription start sites. This fragment of the SAG1 promoter
was already shown to be insufficient to drive transcription
of CAT reporter (Soldati and Boothroyd, 1995), requiring at
least two of the five 27 repeats placed upstream of the −70
bp region of SAG1. Transfection with this construct showed
no RFP expression (data not shown), making it unlikely that
the ENO2 intron contains a transcriptional enhancer.
Next we investigated whether the absence of the ENO2
intron suppresses RFP expression in a manner dependent
on another element in the transcription unit by generating a
series of constructs composed of different assemblies
of ENO2 or Tub5 UTRs. Two new constructs were
derived from prENO2/RFP, in which either the ENO2 5′
UTR (prENO2/5′UTRTUB-RFP) or 3′ UTR (prENO2/RFP-
3′UTRTUB) were replaced with those of Toxoplasma
tubulin gene. Interestingly, 5′-UTR replacement resulted
in expression of RFP (Fig. 4A) whereas the 3′-UTR
exchange had no effect (Fig. 4B). These results indicated
that: (i) the ENO2 5′UTR suppresses expression in the
absence of an intron; and (ii) the ENO2 promoter has
intrinsic transcriptional activity and does not require the
presence of its intron to produce transcripts. To confirm
these data, we also generated two other constructs carry-
ing either the actin 5′-UTR or 3′-UTR in place of those of
ENO2. These constructs showed similar results (data not
shown) of those using the tubulin elements, supporting the
inhibiting role of the ENO2 5′-UTR in absence of the intron.
We next examined whether RFP expression from the
ENO2 cassette requires the ENO2 intron specifically or
merely the presence of any intron is sufficient. To this aim,
we replaced the ENO2 intron in prENO2/RFP + INTENO2
with the similar sized (511 bp) first intron of the tubulin
gene. Parasite transfection with this construct, named
prENO2/RFP + INTTUB, resulted in intermediate expres-
sion of RFP (Fig. 4C), indicating that the ENO2 intron
Fig. 4. The ENO2 5′ UTR suppresses RFP expression in the absence of an intron. PLK tachyzoites were stably transfected with
prENO2/5′UTRTUB-RFP (A), prENO2/RFP-3′UTRTUB (B) or prENO2/RFP + INTTUB (C) along with DHFR resistance cassette. After 8 days of
pyrimethamine selection, stable transfected populations were analyzed by flow cytometry. There were 100 000 events counted for each
transgenic tachyzoites. Untransfected tachyzoites were also analyzed to assess autofluorescence (data not shown). Data are from one
representative experiment out of three with similar results. MFI, mean fluorescence intensity.
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overcomes suppression more efficiently than a heterolo-
gous intron.
Moreover, the ENO2 5′-UTR was capable of suppress-
ing RFP expression even when placed downstream of the
transcription start site of the strong tubulin promoter
(pTUB/5′UTRENO2-RFP, Fig. S1B). The introduction of the
ENO2 intron into the RFP coding region of pTUB/
5′UTRENO2-RFP restored the strong RFP synthesis typical
of the tubulin promoter (Fig. S1C). These findings indicate
that ENO2 5′UTR suppression of an intronless gene does
not depend on promoter type.
We reasoned that suppression of RFP expression by the
ENO2 5′-UTR in the absence of the intron might be due to
an effect on mRNAabundance. To address this, we purified
total RNA from parasites transfected with either prENO2/
RFP + INTENO2 or prENO2/RFP and, after DNase I treat-
ment and reverse transcription, we analyzed the RFP
cDNA abundance by PCR. As shown in Fig. 5, RFP cDNA
was barely detected in parasites transfected with prENO2/
RFP (lane 2), but was abundant in tachyzoites transfected
with prENO2/RFP + INTENO2 (lane 1). PCR analysis of
parasites transfected with prENO2/RFP + INTTUB showed
intermediate abundance of the RFP product (lane 3), in
accordance with the partial restoration of RFP synthesis
observed by flow cytometry (Fig. 4C). Both ENO2 and
tubulin introns were correctly spliced and IR was not
observed in tachyzoites transfected with these constructs.
Taken together, these results indicate that the ENO2
5′UTR and intron are key elements that control the expres-
sion of this gene.
Appropriate expression of ENO1 in bradyzoites requires
a longer ENO1 3′-UTR, but does not require an intron
Kibe et al. (2005) investigated ENO1 promoter activity
several years ago using CAT as a reporter to dissect the
ENO1 expression unit in bradyzoites. IR observed in ENO1
transcripts in tachyzoites prompted us to revisit this gene
with the intention of identifying elements involved in post-
transcriptional regulation of ENO1 expression. We began
this analysis by recreating the same expression cassette
used by Kibe et al. as a starting construct. The expression
cassette, named prENO1/EGFP, consisted of a DNA frag-
ment spanning 1240 bp upstream of the ENO1 ATG fol-
lowed by the EGFP coding region and 322 bp of the ENO1
3′-UTR. PLK parasites were transfected with prENO1/
EGFP, drug selected for 8 days, differentiated to brady-
zoites in alkaline media, and tested for EGFP expression
by fluorescence microscopy (data not shown) and flow
cytometry (Fig. 6B). EGFP expression was barely detect-
able in just a few parasites after prolonged growth in
alkaline media in agreement with the very low expression
level described by Kibe et al. (2005). Next, we wondered
whether expression driven by the ENO1 promoter required
the presence of its unique intron as observed in the ENO2
gene. To assess this, we placed the ENO1 intron into
the EGFP coding region 40 bp upstream of the ATG,
reproducing its location inside the ENO1 gene (prENO1/
EGFP + INTENO1). Unlike the situation for expression of
RFP with the ENO2 intron in tachyzoites, insertion of the
ENO1 intron did not confer EGFP expression in brady-
zoites (Fig. 6C). This unexpected result prompted us to
assess whether the expression cassette lacked a crucial
element. To address this point, we first enlarged the ENO1
expression cassette by replacing the 322 bp ENO1 3′-UTR
with a longer segment of this genomic region spanning
1300 bp downstream of the ENO1 stop codon (prENO1/
EGFP + INTENO1 + LNG3′UTRENO1). Parasite transfection
with this new construct showed no increased EGFP
expression after alkaline conversion (Fig. 6D). Surpris-
ingly, however, the longer ENO1 3′-UTR induced EGFP
expression in bradyzoites transfected with a construct
(prENO1/EGFP + LNG3′UTRENO1) lacking the ENO1 intron
(Fig. 6E).
To help interpret these results, we performed a semi-
quantitative RT-PCR analysis of the EGFP transcripts pro-
Fig. 5. The ENO2 intron affects mRNA abundance. Total RNA was isolated from tachyzoites stably transfected with prENO2/RFP,
prENO2/RFP + INTENO2 or prENO2/RFP + INTTUB along with DHFR resistance plasmid. After 8 days of pyrimethamine selection, total RNAs
were purified from these transgenic parasites. After Dnase I treatment and reverse transcription, cDNAs were analyzed by PCR using primers
to detect RFP (R1F and R1R primers) or tubulin (T5F and T5R primers).
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Fig. 6. EGFP expression driven by the ENO1 promoter is not restored by the ENO1 intron but requires a long 3′ UTR instead. PLK
tachyzoites analyzed as WT parasites (A) or were stably transfected with prENO1/EGFP (B), prENO1/EGFP + INTENO1 (C),
prENO1/EGFP + INTENO1 + LNG3′UTRENO1 (D) or prENO1/EGFP + LNG3′UTRENO1 (E) along with a DHFR resistance plasmid. After 8 days of
pyrimethamine selection and 6 days of alkaline conversion, stable transfected populations were analyzed by flow cytometry. There were
50 000 events counted for each analysis. No expression was seen in tachyzoites (data not shown). Data are from one representative
experiment out of three with similar results. MFI, mean fluorescence intensity.
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duced by parasites carrying prENO1/EGFP, prENO1/
EGFP + LNG3′UTRENO1 or prENO1/EGFP + INTENO1 +
LNG3′UTRENO1 after 6 days of bradyzoite conversion. This
experiment showed that EGFP mRNA abundance was
very low in parasites bearing the short ENO1 3′-UTR
(Fig. 7, lane 1), but was quite abundant in parasites trans-
fected with constructs carrying the long 3′-UTR (Fig. 7,
lanes 2 and 3). Unexpectedly, the EGFP transcript derived
from prENO1/EGFP + INTENO1 + LNG3′UTRENO1 remained
unspliced, suggesting that the lack of EGFP fluorescence
was due to a lack of mRNA splicing (Fig. 7, lane 3). We
tested if replacing EGFP with the RFP in a new plasmid
called prENO1/RFP + INTENO1 + LNG3′UTRENO1 resulted in
a correct removal of the ENO1 intron. Like the previous
EGFP construct, prENO1/RFP + INTENO1 + LNG3′UTRENO1
did not produce fluorescent parasites and the ENO1
intron was still not spliced (data not shown). This result
suggested that the lack of intron splicing was not due to
an element of the EGFP coding region that rendered the
intron cryptic but that, unlike ENO2, the splicing of the
ENO1 intron required supplemental sequences from its
surrounding exons. Together, these findings suggest that
the long 3′-UTR enhances mRNA abundance, but is insuf-
ficient to confer splicing.
To test if the ENO1 exons are required for splicing, we
generated a new set of constructs in which we fused the
coding region of ENO1, with or without its intron, in frame
with EGFP followed by either the short or long ENO1
3′-UTR. Constructs with or without the ENO1 intron car-
rying the short ENO1 3′-UTR showed no ENO1-EGFP
fluorescence in transfected parasites after bradyzoite
conversion (Fig. 8A and B), consistent with the short
3′-UTR being insufficient to confer high mRNA abun-
dance. As expected, the long version of the ENO1 3′-UTR
conferred ENO1-EGFP expression in the absence of an
intron (Fig. 8C). Interestingly, the long version of the
ENO1 3′-UTR conferred ENO1-EGFP expression also
when the ENO1 intron was present (Fig. 8D). These find-
ings confirm that the long 3′UTR enhances mRNA abun-
dance, but does not influence spicing, and they further
suggest that the ENO1 exons are required for correct
splicing of the intron.
To further dissect the role of the ENO1 3′-UTR on
expression in bradyzoites, we asked if it functions in col-
laboration with the ENO1 5′-UTR. To this aim, we tested
whether the ENO1 promoter still required the long ENO1
3′-UTR when the ENO1 5′-UTR is replaced with that of the
tubulin gene in prENO1/EGFP, generating prENO1/
5′UTRTUB-EGFP. Interesting, parasites stably transfected
with this construct showed a strong fluorescence after
bradyzoite induction (Fig 9A, right panel). This result dem-
onstrated that the short ENO1 3-UTR is functional and that
the long 3′-UTR was only required in the presence of the
ENO1 5′UTR. Moreover, EGFP expression was also
slightly detectable in tachyzoites by either fluorescence
microscopy (data not shown) or flow cytometry (Fig. 9A,
left panel). To determine whether this leakiness was due to
ENO1 promoter, we replaced it with the bradyzoite specific
BAG1 promoter in prENO1/5′UTRTUB-EGFP. We observed
no detectable signal in tachyzoites transfected with this
construct by fluorescence microscopy or flow cytometry
(Fig. 9B, left panel), indicating that the observed leakiness
is due to the ENO1 promoter and not to the tubulin 5′-UTR.
Strong fluorescence was detected after bradyzoite induc-
tion (Fig. 9B, right panel). The presence of the tubulin
5′-UTR conferred stronger fluorescence to both ENO1 and
BAG1 promoters compared with those carrying their own 5′
elements, indicating that the tubulin 5′-UTR bestowed
more efficient translation to these transcripts.
We next investigated whether replacement of the ENO1
3′-UTR with that of tubulin was also capable of conveying
EGFP expression. As shown in Fig. 10B, unlike ENO2,
substitution of the ENO1 3′-UTR with that of the tubulin
gene unlocked expression of EGFP. These results sug-
Fig. 7. Supplemental ENO1 3′-UTR sequence enhances EGFP mRNA abundance from the ENO1 promoter. Total RNA was isolated from
alkaline converted parasites expressing prENO1/EGFP (lane 1), prENO1/EGFP + LNG3′UTRENO1 (lane 2) or
prENO1/EGFP + INTENO1 + LNG3′UTRENO1 (lane 3). After Dnase I treatment and reverse transcription, cDNAs were analyzed by PCR using
primers to detect EGFP (EGFPF and EGFPR primers) or BAG1 (B1F and B1R primers).
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gested that sequences in both the 5′- and the 3′-UTR
collaborate to license expression of ENO1 in bradyzoites.
ENO2 IR in bradyzoites is largely maintained upon
expression from the ENO1 promoter
As noted above, unspliced forms of ENO2 are detectable
when PLK parasites were induced to differentiate into
bradyzoites with alkaline media. We wondered whether
expression of the ENO2 RFP reporter cassette under the
ENO1 promoter would result in fluorescent bradyzoites.
To this intent, we replaced the ENO2 promoter with
that of ENO1 in prENO2/RFP + INTENO2 to generate
prENO1/5′UTRENO2 + RFP + INTENO2 + 3′UTRENO2. Stably
transfected parasites were induced to differentiate in
bradyzoites for 6 days with alkaline media, and then ana-
lyzed by fluorescence microscopy and flow cytometry. We
observed fluorescence only in a small fraction of parasites,
and among them a few displayed a strong signal and the
majority a mild fluorescence (Fig. 11A). The same pattern
was obtained in all populations transfected with this con-
struct in independent experiments, indicating that this bias
was not due to inefficient transfection. Deletion of the
ENO2 intron from prENO1/5′UTRENO2 + RFP + INTENO2 +
Fig. 8. ENO1 intron does not restore or enhance EGFP expression when placed in constructs carrying either the short (SHT) or long (LNG)
ENO1 3′-UTR. PLK tachyzoites were stably transfected with either prENO1/ENO1-EGFP + SHT3′UTRENO1 (A),
prENO1/ENO1-EGFP + INTENO1 + SHT3′UTRENO1 (B), prENO1/ENO1-EGFP + LNG3′UTRENO1 (C) or prENO1/ENO1-EGFP + INTENO1 + LNG3′UTRENO1
(D) along with DHFR resistance cassette. After 8 days of pyrimethamine selection and 6 days of alkaline conversion, stable transfected
populations were analyzed by flow cytometry. There were 50 000 events counted for each transgenic tachyzoite/bradyzoite mixture.
Untransfected alkaline-converted parasites were also analyzed to assess autofluorescence (data not shown). Data are from one representative
experiment out of three with similar results. MFI, mean fluorescence intensity.
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3′UTRENO2 resulted in loss of fluorescence (Fig. 11B), con-
firming that the intron is required when the RFP coding
sequence is flanked by the ENO2 5′- and 3′-UTR.
Finally, to determine whether the low RFP expression
driven by this ENO1/ENO2 chimeric transcription unit was
due to intron retention, we purified RNA from prENO2/
RFP + INTENO2 tachyzoites or prENO1/5′UTRENO2 + RFP +
INTENO2 + 3′UTRENO2 bradyzoite-induced parasites to
perform RT-PCR analysis. This analysis revealed that the
ENO2 intron was partially retained only in parasites
Fig. 9. Replacement of the ENO1 5′-UTR with that of tubulin restores EGFP expression in bradyzoites and shows leakiness of the ENO1
promoter in tachyzoites. PLK tachyzoites were stably transfected with either prENO1/5′UTRTUB-EGFP (A) or prBAG1/5′UTRTUB-EGFP (B) along
with a DHFR resistance plasmid. After 8 days of pyrimethamine selection and 6 days of alkaline conversion, stable transfected populations
were analyzed by flow cytometry. There were 50 000 events counted for each transgenic tachyzoite/bradyzoites mixture (right panels). The left
panels show the same analysis performed on tachyzoites (100 000 events were counted). Data are from one representative experiment out of
three with similar results. MFI, mean fluorescence intensity.
Fig. 10. Replacement of ENO1 3′-UTR with
that of tubulin results in EGFP expression
after alkaline conversion. Parasites stably
expressing prENO1/EGFP-3′UTRTUB (B) were
analyzed by flow cytometry after 6 days of
growth in alkaline media. Untransfected
converted parasites (A) were also analyzed to
assess autofluorescence. There were 50 000
events counted. Data are from one
representative experiment out of three with
similar results. MFI, mean fluorescence
intensity.
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expressing RFP by ENO1 promoter after alkaline conver-
sion (Fig. 11C, lane 2). This finding indicated that IR
required factors produced only in either bradyzoites or
during their conversion from tachyzoites.
Expression of the ENO genes is not dependent on
chromosomal context
Epigenetic gene regulation has become known as a main
mechanism for gene regulation in all eukaryotes. Because
T. gondii has a full complement of histone-modifying
enzymes and histones, we wondered whether the
approach we used to investigate expression of ENO genes
had hidden evidence of epigenetic regulation acting on
these genes. To address this point, we exploited the avail-
ability of a type II strain carrying a deletion of the ku80 gene
(generously provided by Dr. Bzik) (Fox et al., 2011). This
Prugniaud Δku80 (PruΔku80) allows the easy targeting of
selected chromosomal loci for knockouts or knockins via
site-specific homologous integration. We generated new
parasite strains in the PruΔku80 background, integrating
the most relevant ENO cassettes into their own original
chromosomal loci by single crossover recombination (see
schematic representation of the approach used in Fig. S2).
Fig. 11. ENO2 intron partially restores RFP expression in bradyzoites. prENO1/5′UTRENO2 + RFP + INTENO2 + 3′UTRENO2 (A) or
prENO1/5′UTRENO2 + RFP+3′UTRENO2 (B) were stably integrated in the PLK genome by co-transfection with a DHFR resistance plasmid and 8
days of pyrimethamine selection. Tachyzoites and 6 days alkaline-converted parasites of these two transgenic strains were analyzed by flow
cytometry. There were 50 000 events counted. No expression was seen in tachyzoites (data not shown). Data are from one representative
experiment out of three with similar results. MFI, mean fluorescence intensity. (C) ENO2 intron is retained in the bradyzoite stage. PLK
tachyzoites expressing prENO2/RFP + INTENO2 were harvested and, after filter purification, used to isolate total RNA. PLK parasites stably
transfected with prENO1/5′UTRENO2 + RFP + INTENO2 + 3′UTRENO2 were induced to differentiate by alkaline media for 6 days and then, after
syringe extrusion from HFF cells and pepsin treatment, used to purify total RNA. After treatment with Dnase I, both RNAs were reverse
transcribed and analyzed by PCR using primers to detect either RFP (R1F and R1R) or tubulin (T5F and T5R). Lane 1: PCR performed on
cDNA generated from prENO2/RFP + INTENO2 tachyzoites; Lane 2: PCR performed on cDNA generated from
prENO1/5′UTRENO2 + RFP + INTENO2 + 3′UTRENO2 parasites after bradyzoite induction. The asterisk indicates nonspecific PCR product.
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Fluorescence microscopy of single clones of PruΔku80
carrying the RFP coding sequence under control of the
most relevant ENO expression cassettes integrated in their
own chromosomal loci showed fluorescence levels similar
to those observed via random integration (Fig. S2). These
data indicated that expression of these two stage-specific
genes was mainly dependent on the intrinsic DNA
sequence than epigenetic regulation. Moreover, this analy-
sis further validated the data presented above, confirming
that the UTRs and intron were key elements of the ENO
transcription units.
Discussion
Tachyzoite-bradyzoite interconversion is the pivotal step
that confers to Toxoplasma its unrivaled capacity to
persist inside its host lifelong. The mechanisms govern-
ing tachyzoite-bradyzoite interconversion remain poorly
understood. Differentiation, which results in cyst formation
mainly in muscles and brain, is accompanied by changes
in expression of glycolytic enzymes, including ENOs and
LDHs. Differential expression of these glycolytic enzymes
may be required to respond to biochemical and metabolic
differences between the rapidly dividing tachyzoite and
the slow-growing bradyzoite (Weiss and Kim, 2013). Mou-
veaux and colleagues recently showed that ENO genes
are capable of binding chromatin to alter expression of a
broad set of genes (Mouveaux et al., 2014). Moreover, the
authors showed that ENO1 ablation resulted in a
decrease of brain cyst burden in infected mice. Thus, a
rapid exchange of the ENO protein expressed by para-
sites may determine the activation of genes that induce
differentiation. In this study, we identified unspliced forms
of ENO and LDH transcripts in parasites that are in the
process of stage conversion. The ENO1 gene was
reported to be exclusively expressed during the brady-
zoite stage (Dzierszinski et al., 2001). We observed that
the bradyzoite-specific ENO1 transcripts are also gener-
ated during tachyzoite stage, albeit in an unspliced form,
in agreement with the absence of ENO1 protein at this
stage. In vitro and intraperitoneal PLK tachyzoites pre-
sented both forms of ENO1, spliced and unspliced. The
intron-retained transcript was the most abundant, and the
mature ENO1 mRNA may be derived from the low per-
centage of bradyzoites that spontaneously convert in vitro
(Soete et al., 1993) and in vivo (Di Cristina et al., 2008).
Accordingly, the ENO1 intron-retained transcript was the
only form detected in RH tachyzoites, a strain of Toxo-
plasma that exhibits low bradyzoite conversion capacity.
Moreover, the immature form of ENO1 was never
detected in samples prepared from PLK cysts purified
from mouse brain, thus indicating that the intron is
retained in tachyzoites exclusively or during the early
transition toward the bradyzoite stage.
Toxoplasma ENO1 and ENO2 genes are differentially
expressed in bradyzoites and tachyzoites respectively.
Between these two glycolytic isoforms of ENO, ENO2
displays the highest enzymatic activity in accordance with
the high metabolism of rapidly multiplying tachyzoites. Like
ENO1, we observed unspliced transcripts of ENO2 only
during a developmental transition, in this case from brady-
zoites to tachyzoites. ENO2 intron-retention was never
observed in RT-PCR experiments using PLK brain cysts, in
vitro tachyzoites or peritoneal tachyzoites as source of
RNA. IR is part of a wider process called alternative
splicing, one of the main mechanisms responsible for
increasing the diversity and complexity of genomes (Zhan,
2013). Splicing events such as exon skipping, truncation,
extension, cryptic exons, and IR have been observed in
many genes of several organisms, particularly in higher
multicellular organisms. IR, which is the least character-
ized form of alternative splicing, consists of the complete
retention of an intron in a mature transcript. IR is often
associated with failure of the recognition of weak splice
sites flanking short introns. Although alternative splicing is
rare in protozoa, IR is the most prevalent type in such
organisms (Kim et al., 2008; Keren et al., 2010). IR can
result in insertion of premature stop codons (PTC) in some
transcripts that are then degraded by nonsense mediated
decay (NMD). Hence, IR can decrease mRNA abundance
via a mechanism that has been called ‘Regulated Unpro-
ductive Splicing and Translation’ (RUST), which regulates
expression of a broad number of genes in many organisms
(Lareau et al., 2007). ENO genes contain a single intron
just downstream of the ATG that introduces a stop codon in
the reading frame. However, these immature transcripts
are likely insensitive to NMD due to the lack of a down-
stream exon junction complex. Another mechanism acti-
vated by IR blocks export of unspliced pre-mRNAs from the
nucleus to the cytoplasm, thus preventing their translation
into aberrant polypeptides (Chang and Sharp, 1989;
Legrain and Rosbash, 1989). Restriction in the nuclei
usually results in degradation of the immature transcripts
by the nuclear exosome machinery.
Unspliced forms of ENO transcripts may allow for rapid
expression of the appropriate new stage-specific glycolytic
enzyme during differentiation. In this model, low gene
expression and retention of the intron could prevent
untimely production of the ENO enzyme until a differentia-
tion signal induces or represses expression of splicing
regulators that dictate the cryptic intron’s fate. A similar
mechanism has been described for the coordinate expres-
sion of a battery of neuronal genes during neurogenesis
(Yap et al., 2012). Retention of an intron in the 3′-UTR of
some neuronal genes by polypyrimidine tract-binding
protein (Ptbp1) restricted these immature transcripts to the
nucleus, leading to their degradation by the nuclear RNA
surveillance machinery. Decreased expression of Ptbp1
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during neuronal differentiation allows intron splicing and
accumulation of translation-competent mRNAs in the cyto-
plasm. Other genes regulated by similar mechanisms
are those coding for proinsulin (Mansilla et al., 2005),
cyclooxygenase-1 (Cui et al., 2004; Qin et al., 2005), mito-
chondrial transcription termination factor (Li et al., 2005)
and gonadotropin-releasing hormone (Seong et al., 1999),
among others. The serine- and arginine-rich protein SF2/
ASF (Sun et al., 2010) autoregulates its expression by
repressing the splicing of some of its introns, while apoli-
poprotein E (APOE; Xu et al., 2008) retains intron 3 spe-
cifically in neuron cells restricting the transcripts in the
nucleus. The splicing of APOE intron 3 is induced in
response to excitotoxic stimuli to increase APOE expres-
sion. Intron-containing transcripts retained in the nucleus
are thus usually targeted to the nuclear exosome for deg-
radation, although several reports described different fates
of these immature messengers. For example, Hett and
West (2014) showed that the pre-mRNAs produced follow-
ing U4 snRNAinhibition were stable in the nucleus and that
nuclear RNA degradation factors did not relocalize to
nuclear speckles following splicing inhibition. Moreover,
the pre-mRNAs remained competent for splicing after
removing the U4 snRNA inhibition. Denis et al. (2005)
reported that interleukin-1 is a component of a subset of
pre-mRNAs that retained introns in mature human plate-
lets. The retained intron of interleukin-1 pre-mRNAs was
spliced to generate mature transcripts, leading to new
synthesis of IL-1β protein in response to cellular activation.
These studies indicate that IR can function as a time-
regulated mechanism to forestall translation and accumu-
late preformed, but translationally incompetent unspliced
transcripts, that cells may utilize at specific developmental
stages. In this work, we have not investigated whether
the immature forms of ENO genes identified during
the tachyzoite-bradyzoite interconversion process were
subject of either delayed splicing and then translation or
degradation. However, because proteins are synthesized
more rapidly from preexisting stored mRNAs than from
genes that require transcriptional activation, it can be
hypothesized that parasites might utilize a developmental
regulated splicing of these transcripts to promptly provide
initial stage-specific ENO to enter differentiation before
upregulating the ENO promoters. Similar to ENO genes,
we identified retained introns in LDH transcripts, suggest-
ing that parasites may utilize this mechanism to tightly
control stage-specific expression. However, unspliced
forms of LDH genes were barely detectable by RT-PCR,
indicating that production of these immature forms was
very low during interconversion compared to ENO genes.
Dissection of the elements composing the ENO tran-
scription units allowed the identification of regions that
regulate ENO expression. To perform this analysis, we
generated several constructs bearing combinations of the
ENO gene elements. Although variables such as trans-
fection efficiency, vector genome locus integration and
bradyzoite conversion efficiency were limitations, our
approach nevertheless allowed the identification of ENO
elements playing roles in transcriptional and posttran-
scriptional processes. As for the ENO2 transcriptional
unit, efficient synthesis of fluorescent reporter was only
observed when the intron was introduced inside the RFP
coding sequence. The intron was only required when the
ENO2 5′-UTR was present, indicating that these two ele-
ments were in some way coupled, perhaps to control
temporal splicing of the transcripts. In the absence of the
intron, the ENO2 promoter drove reporter production, pro-
viding that the 5′-UTR was replaced with that of another
gene such as tubulin or actin. The ENO2 3′-UTR seemed
to play no other role than to terminate transcription. The
introduction of the tubulin intron partially restored expres-
sion of RFP, suggesting that factors binding the ENO2
5′-UTR may interact with the splicing machinery. Moreo-
ver, ENO2 5′-UTR was capable of inhibiting expression
driven by promoters other than ENO2, such as tubulin.
Repression was released by introducing the ENO2 intron
in this construct, confirming that these two elements were
interacting together in some way. We have not investi-
gated the nature of the repression carried out by the
ENO2 5′-UTR, but we hypothesize that may occur by
inhibiting nuclear export in absence of splicing, thus
leading to rapid degradation of the transcripts. This
hypothesis is in accordance with the very low abundance
of RFP transcripts detected by RT-PCR, although we
cannot rule out destabilization of cytoplasmic transcripts
carrying the ENO2 5′-UTR that did not go through the
splicing machinery. Retention of the ENO2 intron was only
observed when the RFP coding sequence, embedded into
the ENO2 5′-UTR and intron, was expressed in the brady-
zoite stage by exploiting the stage specificity of the ENO1
promoter. We observed only partial ENO2 IR with part of
the transcripts fully mature. This result suggests that IR is
likely due to the presence of limiting amounts of splicing
regulators, in accordance with low abundance of ENO
transcripts during early differentiation.
In contrast, an analysis of the ENO1 transcription unit
highlighted that the 5′- and 3′-UTR interacted and the intron
was not essential to generate fluorescence from the ENO1
promoter after parasite conversion into bradyzoites. The
ENO1 intron was not spliced when placed inside the
reporter coding sequence, as occurred for ENO2 intron,
indicating that exonic splicing enhancers (ESEs) may be
required for splicing this intron. Replacing the 5′ or 3′-UTR
with those from other genes such as tubulin resulted in
reporter expression. The ENO1 3′-UTR required a supple-
mental sequence when coupled to its 5′-UTR, whereas the
shorter ENO1 3′-UTR was fully functional in the presence
of a heterologous 5′-UTR.Although difficult to interpret with
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the current information, we speculate that the 5′-UTR may
bind a factor(s) that interact directly or indirectly to
sequences of the longer ENO1 3′-UTR, perhaps to regu-
late temporal intron splicing. That the short version of the
ENO1 3′-UTR inhibited EGFP expression only when
coupled with the ENO1 5′-UTR suggests these two UTR
elements interact. Further, the lack of a supplemental
sequence might have caused this interaction to exert an
inhibition on EGFP expression, perhaps due to factors
assembled improperly on the 5′- and 3′-UTR. Like ENO2
intron-less transcripts, we found very low abundance of
reporter transcripts when the short version of ENO1
3′-UTR was placed in the construct. Introns and UTR
elements have been found to cooperatively dictate expres-
sion of some proteins. For example, an intron present
within the 5′-UTR of the Drosophila male-specific-lethal 2
(msl-2) mRNA is alternatively spliced in a sex-specific
fashion such that the intron is removed in males, but
retained in females (Salz and Erickson, 2010). The msl-2
intron contains two binding sites for Sex-lethal (SXL), an
RNA binding protein known to regulate pre-mRNA splicing
(Cline, 1993; Baker et al., 1994). One binding site is
located adjacent to the 5′ splice site and the other is just
upstream of the 3′ splice site. The SXL binding sites
retained within this intron in the 5′-UTR, combined with
additional SXL binding sites located in the 3′-UTR, are
bound by SXL to inhibit translation of msl-2 mRNA (Abaza
et al., 2006).
Results obtained above were also validated using
another strain, PruΔku80, that allows site-specific integra-
tion of exogenous DNA. The most informative ENO
expression cassettes were integrated in their loci by
single crossing-over events, and single parasite clones
were analyzed by fluorescence microscopy. The impact
on RFP expression by the elements composing the ENO
transcription units, UTRs and introns, was comparable
with that already observed from random integration of the
constructs carried out with the ME49 strain. These results
indicate that expression of these transcription units were
not dependent by locus-specific epigenetic marks.
Taken together, our findings may account for the fine
regulation of the ENO genes reported above, in which
coupled elements of their transcripts (5′-UTR and intron in
ENO2; 5′-UTR and 3′-UTR in ENO1) may interact
together by binding factors involved in the regulated
removal of the introns in response of environmental
signals. In this work, we have not explored whether these
elements bind proteins. This will be the subject of future
investigations. It is conceivable that exploiting these
sequences will identify factors that control the regulated
splicing of ENO transcripts during tachyzoite-bradyzoite
interconversion. Identification of proteins controlling these
events will be fundamental to understanding stage differ-
entiation in Toxoplasma.
Experimental procedures
Host cells and parasite cultures
Human foreskin fibroblasts (HFFs) were grown in Dulbecco’s
modified Eagle’s medium (Invitrogen) containing 10% fetal
bovine serum (Invitrogen). A single T. gondii line, the clonal
isolate PLK of the ME49 strain, was used in all genetic
manipulations described here. The clonal isolate EP of the RH
strain was also used in this study. Parasites were propagated
in vitro by serial passage on monolayers of HFF (Roos et al.,
1994). In vivo PLK tachyzoites were obtained by phosphate-
buffered saline (PBS) lavage of the intraperitoneal (i.p.) cavity
of Swiss-CD1 mice (5 weeks old; Harlan Sprague-Dawley) 4
days postinfection with 104 tachyzoites by i.p. injection.
Cyst purification
Swiss-CD1 mice (5 weeks old; Harlan Sprague-Dawley) were
inoculated with 104 PLK tachyzoites by i.p. injection. Mouse
brains were harvested at 5 weeks postinfection and homog-
enized in 2 ml of PBS by syringe passage through a
19-gauge needle. Cysts were purified from brain by isopycnic
centrifugation as previously described (Cornelissen et al.,
1981; Weiss et al., 1992). Release of bradyzoites from puri-
fied cysts was carried out by incubating purified cysts in
170 mM NaCl/pepsin (0.1 mg ml−1)/60 mM HCl for 30 min at
37°C. Total RNA was extracted from released bradyzoites
using the RNeasy minikit (Qiagen), and 1 μg of RNA was
reverse transcribed using the SuperScript III first-strand syn-
thesis system (Invitrogen) for RT-PCR.
T. gondii transfection experiments
Freshly harvested tachyzoites (2 × 107) were centrifuged to
remove the culture medium, and the resulting pellet was
resuspended in cytomix [120 mM KCl, 0.15 mM CaCl2,
10 mM K2HPO4-KH2PO4 (pH 7.6), 25 mM HEPES (pH 7.6),
2 mM EGTA, 5 mM MgCl2, 2 mM ATP, 5 mM glutathione].
Parasites were resuspended in 700 μl of cytomix containing
100 μg of plasmid DNA to be tested and 5 μg of pyrimeth-
amine resistance cassette. Prior to electroporation, the two
plasmids were linearized with the endonuclease NotI (Black
et al., 1995). The entire mixture was then transferred to an
electroporation cuvette (4-mm gap) and exposed to an elec-
tric pulse with an electroporator (BTX Electro Cell Manipula-
tor 600) in the high-voltage mode (charging voltage and
resistance set at 2.0 kV and 48 W respectively). Electropo-
rated parasites were transferred to fresh HFF monolayers
and subjected to pyrimethamine selection for 8 days prior to
be analyzed by fluorescence microscopy or flow cytometry.
When plasmids carrying the ENO1 promoter were used for
transfection, the 8 days of pyrimethamine selection were
followed by 6 days of bradyzoite conversion in alkaline media
before analysis.
In vitro conversion
In vitro tachyzoite-to-bradyzoite conversion was induced by
exposing parasite cultures to pH 8.2 as described previously
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(Soete et al., 1993; Weiss et al., 1995; Galizi et al., 2013).
Briefly, bradyzoite differentiation was induced in vitro by cul-
turing tachyzoite-infected cells in RPMI 1640 buffered with
50 mM HEPES to pH 8.2, in absence of CO2, and supple-
mented with 3% fetal bovine serum.
RT-PCR analysis
Total RNA was extracted from parasites using the RNeasy
minikit (Qiagen), and 1 μg of RNA was reverse transcribed
using the SuperScript III first-strand synthesis system (Invit-
rogen) for RT-PCR and used as the template for each PCR
(35 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 60 s).
All purified RNAs were treated with DNase I using TURBO
DNA-free™ Kit (Invitrogen) before RT. PCRs were performed
in 20 μl, and the whole reaction products were loaded on a
1% agarose gel. The primers used in these analyses are
listed in Table S1.
Expression vectors
All the expression vectors were generated from the basic
plasmid pBluescript II SK (Stratagene). ENO promoters were
amplified from genomic DNA purified from PLK parasites and
cloned in the ApaI and SalI sites upstream of either EGFP or
RFP. ENO1 and ENO2 promoters were constituted by a DNA
fragment spanning 1240 and 1930 bp upstream of the ATG
respectively. The 3′-UTR segments of both expression cas-
settes were cloned in the restriction sites PacI and NotI
downstream of the reporter. ENO2 3′-UTR was constituted by
a DNA fragment spanning 683 bp downstream of the ENO2
stop codon. The 3′-UTR fragment used in the ENO1 vectors
was composed by 322 and 1300 bp, downstream of the
ENO1 stop codon, in the short and long versions of the ENO1
3′-UTR respectively. All variants of these basic vectors were
achieved by overlap PCR as described by Horton et al.
(1989). The primers used to generate all vectors are listed in
Table S1. All constructs were sequenced to rule out the
occurrence of nucleotide substitutions in either the promoter
or the coding sequences.
Site-specific genomic integration of ENO constructs into
their own loci of PruΔKu80
The strain PruΔKu80 was employed to obtain site-specific
integration of the more informative ENO constructs (Fox et al.,
2011). The pyrimethamine resistance cassette (prSag1/
TgDHFR/3′UTRSAG1) was excised from the backbone using the
restriction enzymes HindIII and NotI and, after blunting the
HindIII end by phusion treatment, cloned in the restriction sites
SpeI (blunted by phusion treatment) and NotI downstream
of the prENO2/RFP, prENO2/RFP + INTENO2 or prENO2/
5′UTRTUB-RFP expression cassettes. Because the PruΔKu80
strain becomes green fluorescent after bradyzoite conversion
due to the presence in its genome of the EGFP coding
sequence under control of the LDH2 promoter, all the site-
specific expression cassettes for analyzing the ENO1 tran-
scription units were first genetically manipulated to replace
EGFP with RFP (using the restriction sites SalI and PacI). The
prENO1/RFP, prENO1/RFP + LNG3′UTRENO1 and prENO1/
5′UTRTUB-RFP expression cassettes were then excised from
the backbone using the restriction enzymes ApaI and NotI
and, after blunting the NotI end by phusion treatment, cloned
in the restriction sites ApaI and XhoI (blunted by phusion
treatment) upstream of the bleomycin resistance cassette
(prGra1/tnBLE/3′UTRSAG1). The prENO2/RFP_TgDHFR,
prENO2/RFP + INTENO2_TgDHFR and prENO2/5′UTRTUB-
RFP_TgDHFR vectors were linearized with NarI to cut within
the ENO2 promoter and used to transfect PruΔKu80.
The prENO1/RFP_ble, prENO1/RFP + LNG3′UTRENO1_ble and
prENO1/5′UTRTUB-RFP_ble vectors were linearized with AatII
to cut within the ENO1 promoter and used to transfect
PruΔKu80. After selection with either pyrimethamine or bleo-
mycin and parasite cloning by limiting dilution, genomic DNA
purified from single clones was analyzed by PCR using
primers designed to detect site-specific genomic integration
(see Fig. S2 for the integration and PCR detection strategy).
Flow cytometry
Parasites purified for transfection were always tested for the
efficiency of plasmid incorporation by setting a separate,
parallel, control transfection using a vector expressing EGFP
under the TUB promoter. Experiments showing < 30% cells
expressing EGFP were discontinued. Transfected parasites
were subjected to pyrimethamine selection for 8 days before
being analyzed by flow cytometry. An analysis of in vitro-
induced bradyzoites was performed after an additional 6 days
of parasite growth in alkaline media. Intracellular parasites
were harvested from in vitro cultures by sequential scraping,
syringing and 3 μm filtering. Bradyzoites were released from in
vitro cysts by digestion in 170 mM NaCl/pepsin (0.1 mg ml−1)/
60 mM HCl for 30 min at 37°C and neutralization with
94 mM Na2CO3. Purified parasites were then analyzed using
FACScan flow cytometer (Becton Dickinson, BD).Autofluores-
cence was assessed using untransfected parasites. For
tachyzoite and bradyzoite analysis, 100 000 and 50 000 para-
sites were acquired respectively. The acquired data were
analyzed with CELLQuest software (BD).
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